February 24, 2025 · Form 4 insider transaction
Mirviss Jeffrey B. sold 4,675 shares of Boston Scientific Corporation at $104.25 per share, a transaction worth $487.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 21, 2024.